Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Bluebird Bio, Inc. (BLUE)  
$0.92 0.01 (1.13%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 139,126,000
Market Cap: 128.39(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.9052 - $5.03
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 27,248 35,533 57,514 116,582
Total Sell Value $35,492 $61,294 $139,194 $443,003
Total People Sold 4 5 5 9
Total Sell Transactions 6 9 12 23
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 939
  Page 6 of 38  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baird William D Iii Chief Financial Officer   •       –      –    2021-02-12 4 S $45.52 $55,352 D/D (1,216) 21,581 29%     
   Cole Jason Chief Operating andLegal Offic   •       –      –    2021-02-02 4 S $45.93 $1,745 D/D (38) 32,785 28%     
   Obenshain Andrew President of SGD   •       –      –    2021-02-02 4 S $45.93 $1,561 D/D (34) 23,884 28%     
   Davidson David Chief Medical Officer   •       –      –    2021-02-02 4 S $45.93 $2,893 D/D (63) 36,298 28%     
   Gregory Philip D Chief Scientific Officer   •       –      –    2021-02-02 4 S $45.93 $2,710 D/D (59) 32,948 28%     
   Leschly Nick President and CEO   •       •      –    2021-02-02 4 S $45.93 $27,280 D/D (594) 86,669 28%     
   Obenshain Andrew President of SGD   •       –      –    2021-01-11 3 IO $0.00 $0 D/D 0 23,918 -39%     
   Ibrahim Ramy   –       •      –    2021-01-07 4 A $0.00 $0 D/D 2,250 2,250     -
   Baird William D Iii Chief Financial Officer   •       –      –    2021-01-06 4 S $44.76 $42,756 D/D (949) 22,797 33%     
   Davidson David Chief Medical Officer   •       –      –    2021-01-06 4 S $44.76 $142,684 D/D (3,167) 36,361 33%     
   Smith-Farrell Joanne COO, Oncology   •       –      –    2021-01-06 4 S $44.76 $57,984 D/D (1,287) 20,609 33%     
   Gregory Philip D Chief Scientific Officer   •       –      –    2021-01-06 4 S $44.76 $124,077 D/D (2,754) 33,007 33%     
   Finger Alison Cecily Chief Commercial Officer   •       –      –    2021-01-06 4 S $44.76 $81,727 D/D (1,814) 25,103 33%     
   Cole Jason Chief Operating andLegal Offic   •       –      –    2021-01-06 4 S $44.76 $106,236 D/D (2,358) 32,823 33%     
   Leschly Nick President and CEO   •       •      –    2021-01-06 4 S $44.76 $454,814 D/D (10,095) 87,263 33%     
   Davidson David Chief Medical Officer   •       –      –    2021-01-05 4 S $44.95 $2,158 D/D (48) 39,528 33%     
   Smith-Farrell Joanne COO, Oncology   •       –      –    2021-01-05 4 S $44.95 $1,888 D/D (42) 21,896 33%     
   Gregory Philip D Chief Scientific Officer   •       –      –    2021-01-05 4 S $44.95 $2,023 D/D (45) 35,761 33%     
   Finger Alison Cecily Chief Commercial Officer   •       –      –    2021-01-05 4 S $44.95 $1,798 D/D (40) 26,917 33%     
   Cole Jason Chief Operating andLegal Offic   •       –      –    2021-01-05 4 S $44.95 $1,933 D/D (43) 35,181 33%     
   Leschly Nick President and CEO   •       •      –    2021-01-05 4 S $44.95 $14,969 D/D (333) 97,358 33%     
   Cole Jason Chief Operating andLegal Offic   •       –      –    2020-11-02 4 S $52.51 $1,960 D/D (37) 35,262 37%     
   Leschly Nick President and CEO   •       •      –    2020-11-02 4 S $52.51 $23,506 D/D (444) 98,135 37%     
   Smith-Farrell Joanne COO, Oncology   •       –      –    2020-11-02 4 S $52.51 $1,960 D/D (37) 21,976 37%     
   Davidson David Chief Medical Officer   •       –      –    2020-11-02 4 S $52.51 $3,335 D/D (63) 39,640 37%     
  939 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 38
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us